Discover the role of biomarkers in diagnosing and managing Inflammatory Bowel Disease (IBD), including Crohn's Disease and ...

Researchers at the University of Michigan have delved deeper into the relationship between manganese deficiency and ...

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic conditions that significantly ...

The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's drug, Tremfya, to treat adults with ...

Inflammatory bowel disease (IBD) is a complex condition that extends beyond clinical symptoms, profoundly impacting patients’ ...

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disorder of the gastrointestinal (GI) tract that significantly impacts the ...

Scientists have found a link between manganese deficiency and both inflammatory bowel disease (IBD) and increased inflammation and damage in the intestine. | Genetics And Genomics ...

Limited PatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder ...

Researchers at the University of Jyväskylä, Finland, are developing a promising method to support the diagnosis of ...

Johnson & Johnson (JNJ) gains FDA approval to expand the labeling for its monoclonal antibody Tremfya for ulcerative colitis.

Numerous biological agents are currently available for the treatment of patients with inflammatory bowel disease (IBD). These agents have shown to be good promising alternatives, or supplements to ...